Home Newsfeeds CORRECTION: Lipocine Q4 EPS $(0.03), Inline

CORRECTION: Lipocine Q4 EPS $(0.03), Inline

Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year.

byHappy Mohamed

March 10, 2023

1 minute read

Broadcom Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

By Avi Kapoor

June 11, 9:51 AM

Broadcom Inc. (NASDAQ:AVGO) is set to release second-quarter financial results, after the closing bell on Wednesday. Analysts expect…

AVGO

Paragon Calls Out OPT’s Inaccurate Statements About Voting On The Blue Proxy Card; Says “Vote The Blue Proxy Card And Put An End To The Corporate Greed And Drowning Share Price”

By Benzinga Newsdesk

January 22, 11:08 AM

Paragon Technologies, Inc. ("Paragon"), a diversified holding company, owning approximately 4.8% of the outstanding shares of Ocean Power Technologies, Inc. (NYSE:OPTT), ("Company") ("OPT"), asks shareholders to

OPTT

Exact Sciences Announces Preliminary Q4 2023 Results; Sees Q4 Revenue $645.5M-$647.5M Vs $631.52M Est.; FY23 Revenue $2.4985B-$2.5005B Vs $2.48B Est.; FY24 Revenue $2.83B Vs $2.83B Est.

By Benzinga Newsdesk

January 7, 6:22 PM

Anticipates record fourth-quarter revenue, expects full-year 2024 revenue of $2.83 billion, submits next-generation Cologuard® to FDAAnnounces Chief Financial Officer succession planHighlighted announcements:Expects

EXAS

YouTube Stars’ Energy Drink Under FDA Review After Senate Majority Leader Raises Concern

By Vandana Singh

July 13, 9:26 AM

The FDA is currently assessing concerns raised by Senate Majority Leader Chuck Schumer about the high caffeine content in a popular energy drink called Prime Energy. The drink, founded by YouTube stars Logan Paul and KSI, is allegedly being marketed to children and teens.

CELH

CORRECTION: Lipocine Q4 EPS $(0.03), Inline

Related Posts

Broadcom Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Paragon Calls Out OPT’s Inaccurate Statements About Voting On The Blue Proxy Card; Says “Vote The Blue Proxy Card And Put An End To The Corporate Greed And Drowning Share Price”

Exact Sciences Announces Preliminary Q4 2023 Results; Sees Q4 Revenue $645.5M-$647.5M Vs $631.52M Est.; FY23 Revenue $2.4985B-$2.5005B Vs $2.48B Est.; FY24 Revenue $2.83B Vs $2.83B Est.

YouTube Stars’ Energy Drink Under FDA Review After Senate Majority Leader Raises Concern